Search Results | Showing 21 - 30 of 42 results for "Life sciences" |
| | | ... natural fit for UniSuper, given our rich heritage in the higher education and research sector." ISPT healthcare and life sciences general manager Robert Pepicelli concurred. "This latest partnership reflects our desire to invest in real estate for purpose ... |
| | | | ... to develop a medical office building in Melbourne, their first direct property acquisition in the healthcare and life sciences sector. ISPT and HESTA as mandate partner will co-develop an on-hospital-campus medical office building of circa 12,000 sqm ... |
| | | | ... retail and industrial have also forced investors to look to other 'alternatives'. Cold storage, data centres, life sciences, student accommodation, and senior living are among the sub-sectors that investors will target in 2022 amid the pandemic ... |
| | | | ... increased significantly during 2021 and we're also fielding considerable interest in alterative asset classes such as life sciences and data centres," he said. |
| | | | ... acquired Modern Risk Solutions, an insurance and risk advisory specialist focused on emerging tech, startup and life sciences. The acquisition sees Modern Risk continue operating as a discrete entity, to be referred to as Modern Risk - a Honan Company. ... |
| | | | ... to virology and oncology. Royalty Pharma, which is in the business of acquiring pharmaceutical royalties in the life sciences industry, will provide information on medical conditions, clinical trials, therapies and technologies that may lead to breakthrough ... |
| | | | ... this could help keep them safe," HESTA chief investment officer Sonya Sawtell-Rickson said. "Our investments in life sciences are supporting jobs and growth in the sector where HESTA members work, while making a positive contribution to their financial ... |
| | | | ... recommended solutions," he said. "These include data centers... However, we are also looking further into areas such as life sciences, bio-medical and industrial cold storage." Despite the heavy sell off in REITs in March and several macro forces still ... |
| | | | ... the government's $500 million Biomedical Translation Fund (BTF). Brandon Capital will drive the development of its life sciences fund, the Medical Research Commercialisation Fund, as part of a government initiative to make Australia a global leader in ... |
| | | | ... capital investment and foreign interest. Sauer said: "Sectors traditionally attractive to venture capital, such as life sciences and information and communication technology, will continue to grow due to increased capital availability and support courtesy ... |
|